Artificial Intelligence-Based Classification and Prognostic Prediction in Small Bowel Crohn's Disease
Establishment and Application of an Artificial Intelligence-Driven Precision Classification and Prognostic Prediction System for Small Bowel Crohn's Disease
1 other identifier
observational
437
1 country
1
Brief Summary
This retrospective observational study aims to develop an artificial intelligence-based system for the precise classification and prognostic prediction of small bowel Crohn's disease. The study includes 437 patients with Crohn's disease who were hospitalized at Shanghai Tenth People's Hospital between January 1, 2020, and January 31, 2025. Clinical information, laboratory results, endoscopic findings, computed tomography enterography or magnetic resonance enterography images, and available pathological and molecular data will be collected from existing medical records. Artificial intelligence-based image segmentation and multimodal analysis will be used to identify and quantify intestinal lesions, strictures, mesenteric changes, fistulas, abscesses, and other disease characteristics. The study will examine whether these features can classify patients more accurately and predict clinical outcomes, including response to medical treatment, treatment failure or switching, and the need for surgery. The resulting system may support individualized assessment and clinical decision-making for patients with small bowel Crohn's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedFirst Submitted
Initial submission to the registry
August 6, 2026
CompletedFirst Posted
Study publicly available on registry
August 11, 2026
CompletedAugust 11, 2026
August 1, 2026
5.8 years
August 6, 2026
August 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Discriminative Performance of the Artificial Intelligence-Based Multimodal Model for Predicting 12-Month Clinical Outcomes
The area under the receiver operating characteristic curve will be used to evaluate the ability of the artificial intelligence-based multimodal model to predict the patient's clinical outcome. Clinical outcomes will be classified as effective medical treatment, treatment failure or recurrence requiring treatment switching, or Crohn's disease-related intestinal surgery.
Within 12 months after the index CTE or MRE examination
Secondary Outcomes (2)
Sensitivity and Specificity of the Multimodal Prediction Model
Within 12 months after the index CTE or MRE examination
Proportion of Patients Requiring Treatment Switching
Within 12 months after the index CTE or MRE examination
Study Arms (3)
Effective Medical Treatment
Patients with small bowel Crohn's disease who achieved and maintained an effective clinical response to medical treatment without treatment switching or Crohn's disease-related surgery during the prespecified follow-up period.
Treatment Failure or Switching
Patients with small bowel Crohn's disease who experienced an inadequate response, loss of response, or disease recurrence requiring a switch in medical treatment during the prespecified follow-up period.
Crohn's Disease-Related Surgery
Patients with small bowel Crohn's disease who underwent Crohn's disease-related intestinal surgery because of disease activity, intestinal stricture or obstruction, penetrating complications, or other Crohn's disease-related indications during the prespecified follow-up period.
Interventions
Existing CTE or MRE images will be analyzed using interactive artificial intelligence-based image segmentation. Imaging features will be integrated with available clinical, laboratory, endoscopic, pathological, and molecular data to classify small bowel Crohn's disease and predict subsequent clinical outcomes. This retrospective observational study does not assign any treatment or alter routine clinical care.
Eligibility Criteria
The study population consists of patients with small bowel Crohn's disease who were hospitalized in the Department of Gastroenterology at Shanghai Tenth People's Hospital between January 1, 2020, and January 31, 2025. Eligible patients will be identified retrospectively from existing medical records. Patients must have adequate CTE or MRE images and sufficient clinical and follow-up information for multimodal feature extraction and assessment of subsequent treatment response, treatment switching, or Crohn's disease-related intestinal surgery.
You may qualify if:
- Diagnosis of Crohn's disease established according to the European Crohn's and Colitis Organisation criteria based on clinical, endoscopic, radiological, and/or histopathological findings.
- Small bowel involvement confirmed by computed tomography enterography, magnetic resonance enterography, endoscopy, surgery, and/or histopathology.
- Availability of CTE or MRE images obtained before treatment and during follow-up. Follow-up imaging was performed within 6 months after treatment for patients with active disease or within 1 to 2 years for patients in remission.
- Availability of sufficient clinical and follow-up information to determine treatment response, treatment switching, or Crohn's disease-related surgery.
You may not qualify if:
- Failure to receive regular medical treatment or follow-up.
- Incomplete clinical or laboratory data that prevent assessment of the prespecified variables or clinical outcomes.
- Poor-quality or incomplete CTE or MRE images that prevent reliable image segmentation or evaluation.
- Presence of a malignant tumor.
- Presence of severe comorbidities, including heart failure or other severe organ dysfunction, that may substantially affect clinical outcomes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Tenth People's Hospital of Shanghai
Shanghai, Shanghai Municipality, 201505, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
August 6, 2026
First Posted
August 11, 2026
Study Start
January 1, 2020
Primary Completion
October 31, 2025
Study Completion
April 30, 2026
Last Updated
August 11, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share